ArticleGynecologic oncology2019

A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer.

Kathleen N Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.